The resources needed to treat fulminant myocarditis—severe, inflammation of the heart that develops rapidly—are outlined in a new Scientific Statement (Statement) from the American Heart Association on how best to reduce fatalities from this rare condition. The Statement is published today in the Association’s premier cardiovascular journal Circulation.
Read More